Future options of anti-angiogenic cancer therapy

Chinese Journal of Cancer
Yihai Cao

Abstract

In human patients, drugs that block tumor vessel growth are widely used to treat a variety of cancer types. Many rigorous phase 3 clinical trials have demonstrated significant survival benefits; however, the addition of an anti-angiogenic component to conventional therapeutic modalities has generally produced modest survival benefits for cancer patients. Currently, it is unclear why these clinically available drugs targeting the same angiogenic pathways produce dissimilar effects in preclinical models and human patients. In this article, we discuss possible mechanisms of various anti-angiogenic drugs and the future development of optimized treatment regimens.

References

Jan 1, 1991·British Medical Bulletin·I J Fidler
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Feb 22, 1996·Nature·P TodorovM Tisdale
Sep 17, 1999·The American Journal of Pathology·A J ManiotisM J Hendrix
Feb 10, 2000·The American Journal of Pathology·R FolbergA J Maniotis
Apr 20, 2001·The International Journal of Biochemistry & Cell Biology·Y Cao
Jul 13, 2002·The Journal of Pathology·Balázs DömeJózsef Tímár
Aug 31, 2002·Endothelium : Journal of Endothelial Cell Research·William P J LeendersRobert M W de Waal
Aug 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D RibattiF Dammacco
Sep 6, 2003·Cancer Cell·Barbara BlouwGabriele Bergers
Mar 23, 2004·Seminars in Thrombosis and Hemostasis·Yihai Cao, Lexun Xue
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Sep 21, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Tomomi KambaDonald M McDonald
Oct 4, 2006·The Journal of Clinical Investigation·Michael R MancusoDonald M McDonald
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Mar 31, 2007·Nature Reviews. Drug Discovery·Judah Folkman
Oct 3, 2007·The Journal of Clinical Investigation·Lars Johan NissenYihai Cao
Dec 7, 2007·Cancer Biology & Therapy·Neelima DenduluriSandra M Swain
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Apr 12, 2008·The New England Journal of Medicine·Ian E Haines, George L Gabor Miklos
Aug 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kaustabh GhoshDonald E Ingber
Nov 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yuan XueYihai Cao
Feb 7, 2009·The New England Journal of Medicine·Jolien TolCornelis J A Punt
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Yihai Cao
Nov 6, 2009·Stem Cells and Development·Domenico Ribatti
Nov 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Samantha Lin Chiou LeeYihai Cao
Apr 8, 2010·Science Translational Medicine·Yihai Cao, Robert Langer
Aug 5, 2010·Nature Reviews. Clinical Oncology·Yihai Cao
Dec 4, 2010·Nature Protocols·Pegah RouhiYihai Cao
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Danfang ZhangYihai Cao

❮ Previous
Next ❯

Citations

Mar 13, 2018·Medicinal Research Reviews·Michael YamakawaDimitri T Azar
Nov 8, 2017·International Journal of Molecular Sciences·Ana CavacoJohannes A Eble
Oct 27, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Peter GálKarel Smetana
Mar 3, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Haet Nim LimHye Jin Jung
Mar 8, 2019·Endocrine Journal·Sadegh RajabiMehdi Hedayati
Nov 7, 2019·International Journal of Molecular Sciences·Tomas KoltaiStephan J Reshkin
Aug 21, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Xian LinBaocun Sun
Nov 9, 2016·International Journal of Oncology·Ewa MajJoanna Wietrzyk
Mar 16, 2018·Oxidative Medicine and Cellular Longevity·Himangshu SonowalKota V Ramana
Jan 19, 2020·International Journal of Molecular Sciences·Wafaa S RamadanAdel Elmoselhi
Feb 26, 2016·Chinese Journal of Cancer·Francesco PezzellaChao-Nan Qian
Aug 8, 2020·Frontiers in Physiology·Yingye FangP I Imoukhuede
May 29, 2020·Human Vaccines & Immunotherapeutics·Jun ZhaoJing Lu
Apr 17, 2020·Life Sciences·Sekaran SaravananVenil N Sumantran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.